QP Release and Batch Certification in Clinical Trials: Meeting EU GMP Standards with Qualified Person Oversight
In the complex lifecycle of pharmaceutical development, ensuring that patients receive safe, effective, and high-quality medication is paramount. This responsibility becomes even more critical—and tightly regulated—during clinical trials. For investigational medicinal products (IMPs) entering or circulating within the European Union (EU) and European Economic Area (EEA), a...
0 Kommentare 0 Geteilt 35 Ansichten 0 Bewertungen